Endoscopic Extirpation of Benign Breast Tumors Using a Lateral Chest Wall Incision

The Feasibility Analysis of Endoscopic Extirpation of Benign Breast Tumors Using Lateral Chest Wall Incision: The Feasibility Analysis of Minimally Invasive Excision for Benign Breast Tumors Via Lateral Chest Wall Approach

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06472700

Enrollment

Registered

2024-06-25

Start date

2021-10-01

Completion date

2023-11-30

Last updated

2024-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Breast Tumors, Endoscopic Breast Surgery

Brief summary

1. A new surgical method for breast surgery has been introduced, which involves the removal of benign breast tumors through endoscopic surgery, thereby avoiding noticeable scarring on the breast. 2. The feasibility of this surgery, key technical points, and potential complications have been analyzed.

Interventions

OTHERNo intervention

No intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

14 Years to 42 Years

Healthy volunteers

Yes

Inclusion criteria

1. Female breast benign tumor patients 2. Received endoscopic resection of benign breast tumors via a lateral chest wall approach.

Exclusion criteria

1. Patients who are unable to comply with follow-up requirements 2. Patients with a history of breast sugery 3. Breast cancer patients

Design outcomes

Primary

Measure	Time frame	Description
Cosmetic Outcome After Endoscopic Benign Breast Tumor Resection	1-3 months post-surgery.	Through outpatient questionnaires and physician-rated photo evaluations

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026